Predictors of undetectable plasma viral load in HIV-positive adults receiving antiretroviral therapy in Southern Brazil
Autor(a) principal: | |
---|---|
Data de Publicação: | 2002 |
Outros Autores: | , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Brazilian Journal of Infectious Diseases |
Texto Completo: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702002000400003 |
Resumo: | Factors associated with undetectable viral load (<80 copies/ml) were investigated among non-pregnant adults in antiretroviral treatment in a specialized service for HIV/AIDS in Southern Brazil. Use of antiretrovirals was investigated in two interviews (one month interval). Clinical data were collected from the clinical records; viral load previous to adherence measurement was defined the viral load previous to the first interview; the final viral load, the viral load subsequent to the second interview (interval between measures approximately 6 months). Undetectable final viral load occurred in 48% of the patients and was positively associated with levels of treatment adherence (p<0.001), being 19% for less than 60% of adherence and about 60% for adherence greater than 80%. In the multivariate model, the odds of undetectable final viral load was four times greater for 80-94% and > or = 95% of adherence (CI 95% 1,80-13,28; CI 95% 1,73-9,53), compared with less than 60% adherence; it was greater for less than 6 months in treatment (OR = 3.37; CI 95% 1.09-10.46); and smaller for viral load previous to adherence measurement > or = 5.2 log10 (OR = 0.19; CI95% 0.06-0.58), adjusted for these variables and sex, age, clinical status, current immune status, group of drugs and interval between the two measurements of viral load. The crude odds were lower for age 16-24 years and use of Nucleoside Analog Reverse Transcriptase Inhibitors only, but these effects were not significant in the multivariate model. There was no evidence of effect of sex, clinical status, current immune status, and changes in treatment regimen. Treatment adherence gave the largest effect. Motivational interventions directed at adherence may improve treatment effectiveness. |
id |
BSID-1_6a0c2c91b90b28eee0b371022388197a |
---|---|
oai_identifier_str |
oai:scielo:S1413-86702002000400003 |
network_acronym_str |
BSID-1 |
network_name_str |
Brazilian Journal of Infectious Diseases |
repository_id_str |
|
spelling |
Predictors of undetectable plasma viral load in HIV-positive adults receiving antiretroviral therapy in Southern BrazilHIVantiretroviral therapyadherenceviral loadpredictorsrisk factorsFactors associated with undetectable viral load (<80 copies/ml) were investigated among non-pregnant adults in antiretroviral treatment in a specialized service for HIV/AIDS in Southern Brazil. Use of antiretrovirals was investigated in two interviews (one month interval). Clinical data were collected from the clinical records; viral load previous to adherence measurement was defined the viral load previous to the first interview; the final viral load, the viral load subsequent to the second interview (interval between measures approximately 6 months). Undetectable final viral load occurred in 48% of the patients and was positively associated with levels of treatment adherence (p<0.001), being 19% for less than 60% of adherence and about 60% for adherence greater than 80%. In the multivariate model, the odds of undetectable final viral load was four times greater for 80-94% and > or = 95% of adherence (CI 95% 1,80-13,28; CI 95% 1,73-9,53), compared with less than 60% adherence; it was greater for less than 6 months in treatment (OR = 3.37; CI 95% 1.09-10.46); and smaller for viral load previous to adherence measurement > or = 5.2 log10 (OR = 0.19; CI95% 0.06-0.58), adjusted for these variables and sex, age, clinical status, current immune status, group of drugs and interval between the two measurements of viral load. The crude odds were lower for age 16-24 years and use of Nucleoside Analog Reverse Transcriptase Inhibitors only, but these effects were not significant in the multivariate model. There was no evidence of effect of sex, clinical status, current immune status, and changes in treatment regimen. Treatment adherence gave the largest effect. Motivational interventions directed at adherence may improve treatment effectiveness.Brazilian Society of Infectious Diseases2002-08-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702002000400003Brazilian Journal of Infectious Diseases v.6 n.4 2002reponame:Brazilian Journal of Infectious Diseasesinstname:Brazilian Society of Infectious Diseases (BSID)instacron:BSID10.1590/S1413-86702002000400003info:eu-repo/semantics/openAccessSilveira,Marysabel Pinto TelisDraschler,Maria de LourdesLeite,José Carlos de CarvalhoPinheiro,Cezar Arthur TavaresSilveira,Vera Lúcia daeng2003-04-01T00:00:00Zoai:scielo:S1413-86702002000400003Revistahttps://www.bjid.org.br/https://old.scielo.br/oai/scielo-oai.phpbjid@bjid.org.br||lgoldani@ufrgs.br1678-43911413-8670opendoar:2003-04-01T00:00Brazilian Journal of Infectious Diseases - Brazilian Society of Infectious Diseases (BSID)false |
dc.title.none.fl_str_mv |
Predictors of undetectable plasma viral load in HIV-positive adults receiving antiretroviral therapy in Southern Brazil |
title |
Predictors of undetectable plasma viral load in HIV-positive adults receiving antiretroviral therapy in Southern Brazil |
spellingShingle |
Predictors of undetectable plasma viral load in HIV-positive adults receiving antiretroviral therapy in Southern Brazil Silveira,Marysabel Pinto Telis HIV antiretroviral therapy adherence viral load predictors risk factors |
title_short |
Predictors of undetectable plasma viral load in HIV-positive adults receiving antiretroviral therapy in Southern Brazil |
title_full |
Predictors of undetectable plasma viral load in HIV-positive adults receiving antiretroviral therapy in Southern Brazil |
title_fullStr |
Predictors of undetectable plasma viral load in HIV-positive adults receiving antiretroviral therapy in Southern Brazil |
title_full_unstemmed |
Predictors of undetectable plasma viral load in HIV-positive adults receiving antiretroviral therapy in Southern Brazil |
title_sort |
Predictors of undetectable plasma viral load in HIV-positive adults receiving antiretroviral therapy in Southern Brazil |
author |
Silveira,Marysabel Pinto Telis |
author_facet |
Silveira,Marysabel Pinto Telis Draschler,Maria de Lourdes Leite,José Carlos de Carvalho Pinheiro,Cezar Arthur Tavares Silveira,Vera Lúcia da |
author_role |
author |
author2 |
Draschler,Maria de Lourdes Leite,José Carlos de Carvalho Pinheiro,Cezar Arthur Tavares Silveira,Vera Lúcia da |
author2_role |
author author author author |
dc.contributor.author.fl_str_mv |
Silveira,Marysabel Pinto Telis Draschler,Maria de Lourdes Leite,José Carlos de Carvalho Pinheiro,Cezar Arthur Tavares Silveira,Vera Lúcia da |
dc.subject.por.fl_str_mv |
HIV antiretroviral therapy adherence viral load predictors risk factors |
topic |
HIV antiretroviral therapy adherence viral load predictors risk factors |
description |
Factors associated with undetectable viral load (<80 copies/ml) were investigated among non-pregnant adults in antiretroviral treatment in a specialized service for HIV/AIDS in Southern Brazil. Use of antiretrovirals was investigated in two interviews (one month interval). Clinical data were collected from the clinical records; viral load previous to adherence measurement was defined the viral load previous to the first interview; the final viral load, the viral load subsequent to the second interview (interval between measures approximately 6 months). Undetectable final viral load occurred in 48% of the patients and was positively associated with levels of treatment adherence (p<0.001), being 19% for less than 60% of adherence and about 60% for adherence greater than 80%. In the multivariate model, the odds of undetectable final viral load was four times greater for 80-94% and > or = 95% of adherence (CI 95% 1,80-13,28; CI 95% 1,73-9,53), compared with less than 60% adherence; it was greater for less than 6 months in treatment (OR = 3.37; CI 95% 1.09-10.46); and smaller for viral load previous to adherence measurement > or = 5.2 log10 (OR = 0.19; CI95% 0.06-0.58), adjusted for these variables and sex, age, clinical status, current immune status, group of drugs and interval between the two measurements of viral load. The crude odds were lower for age 16-24 years and use of Nucleoside Analog Reverse Transcriptase Inhibitors only, but these effects were not significant in the multivariate model. There was no evidence of effect of sex, clinical status, current immune status, and changes in treatment regimen. Treatment adherence gave the largest effect. Motivational interventions directed at adherence may improve treatment effectiveness. |
publishDate |
2002 |
dc.date.none.fl_str_mv |
2002-08-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702002000400003 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702002000400003 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
10.1590/S1413-86702002000400003 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html |
dc.publisher.none.fl_str_mv |
Brazilian Society of Infectious Diseases |
publisher.none.fl_str_mv |
Brazilian Society of Infectious Diseases |
dc.source.none.fl_str_mv |
Brazilian Journal of Infectious Diseases v.6 n.4 2002 reponame:Brazilian Journal of Infectious Diseases instname:Brazilian Society of Infectious Diseases (BSID) instacron:BSID |
instname_str |
Brazilian Society of Infectious Diseases (BSID) |
instacron_str |
BSID |
institution |
BSID |
reponame_str |
Brazilian Journal of Infectious Diseases |
collection |
Brazilian Journal of Infectious Diseases |
repository.name.fl_str_mv |
Brazilian Journal of Infectious Diseases - Brazilian Society of Infectious Diseases (BSID) |
repository.mail.fl_str_mv |
bjid@bjid.org.br||lgoldani@ufrgs.br |
_version_ |
1754209238285025280 |